Perindopril [orch, phsu]
Based [ftcn]
Blood Pressure [orgf]
lowering [spco]
Cerebrovascular disease [patf]
Consistency [qlco]
Benefits [qnco]
Age [orga]
Sex [orgf]
Region [geoa]
Objective [inpr]
Consistency [qlco]
Benefits [qnco]
Blood Pressure [orgf]
lowering [spco]
secondary [neop]
Stroke risk [inpr]
Age [orga]
Sex [orgf]
Geographic Region [geoa]
Recruitment [acty]
Design [acty]
randomized controlled trial [inpr, resa]
placebo [topp]
participants [popg]
randomized [resa]
Angiotensin-converting enzyme inhibitor [phsu]
Perindopril [orch, phsu]
Diuretic [phsu]
Indapamide [orch, phsu]
Indicated [fndg]
Contraindicated [fndg]
placebo [topp]
Main [qlco]
Cox Proportional Hazards Models [inpr, qnco]
Intention [menp]
Basis [ftcn]
subgroup [virs]
Proportion [qnco]
Take [hlca]
Single [popg]
Drug Therapy [topp]
setting [ftcn]
centres [spco]
Asia [geoa]
Australia [geoa]
New Zealand [geoa]
Europe [geoa]
participants [popg]
Patients [podg]
N NOS [aapp, imft]
History [ocdi]
Stroke [dsyn]
Transient Ischemic Attack [dsyn]
Aged [orga]
baseline [bodm]
Women [popg]
Asia [geoa]
Main [qlco]
Measure [qnco]
Stroke [dsyn]
coronary heart disease [dsyn]
vascular [bpoc]
Events [evnt]
treatment [ftcn]
Reduced [qlco]
Stroke [dsyn]
vascular [bpoc]
Events [evnt]
reductions [npop]
subgroups [virs]
Defined [cnce]
Age [orga]
Equal [qlco]
Sex [orgf]
Region [geoa]
Asia [geoa]
treatment [ftcn]
Well [qlco]
Absolute [qlco]
Benefits [qnco]
Large [qnco]
treatment [ftcn]
Expected [idcn]
vascular [bpoc]
Event [evnt]
Patients [podg]
Age [orga]
Sex [orgf]
Region [geoa]
subgroups [virs]
Large [qnco]
Benefits [qnco]
Young [tmco]
participants [popg]
Asia [geoa]
Conclusions [idcn]
Blood Pressure [orgf]
lowering [spco]
secondary [neop]
Stroke risk [inpr]
Large [qnco]
Absolute [qlco]
Benefits [qnco]
Group [idcn]
Defined [cnce]
Age [orga]
Sex [orgf]
Geographic Region [geoa]
